Newtown, PA, United States of America

William E Neway, Iii


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 43(Granted Patents)


Location History:

  • Newtown, PA (US) (2007)
  • Newton, PA (US) (2007 - 2009)

Company Filing History:


Years Active: 2007-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of William E Neway, III

Introduction

William E Neway, III is a notable inventor based in Newtown, PA, with a focus on pharmaceutical innovations. He holds three patents that contribute significantly to the field of medicine, particularly in treating immune-mediated diseases.

Latest Patents

One of his latest patents involves Edg receptor agonists. This invention encompasses compounds of Formula 1, along with their pharmaceutically acceptable salts and hydrates. These compounds are particularly useful for treating immune-mediated diseases and conditions, such as bone marrow, organ, and tissue transplant rejection. Additionally, he has developed aminoalkylphosphonates and related compounds as Edg receptor agonists. Similar to his previous patent, this invention also includes compounds of Formula (I) and is aimed at addressing immune-mediated diseases and conditions.

Career Highlights

Throughout his career, William E Neway, III has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Merck + Co., Inc. His contributions to these organizations have been instrumental in advancing medical research and development.

Collaborations

He has collaborated with notable coworkers such as Jeffrey John Hale and Christopher L Lynch, further enhancing the impact of his work in the field.

Conclusion

William E Neway, III's innovative contributions to pharmaceutical science demonstrate his commitment to improving healthcare through his inventions. His work continues to influence the treatment of critical medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…